MoonLake Immunotherapeutics

MLTX

Equity

ISIN KY61559X1045 / Valor 118139749

NASDAQ (2026-02-26)

USD 17.68-2.96%

MoonLake Immunotherapeutics
UMushroom community rating:

4.00 2 votes No rating yet

NegativeNeutralPositive

About company

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory diseases. The company's primary asset is Sonelokimab, an investigational Nanobody® designed to target and treat inflammation more effectively. By leveraging advanced biotechnological approaches, MoonLake aims to improve patient outcomes in conditions characterized by chronic inflammation. The company is dedicated to advancing Sonelokimab through clinical trials to establish its efficacy and safety, positioning itself as a key player in the biopharmaceutical industry’s efforts to address unmet medical needs in inflammatory diseases.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-58.3%1Y

-1.78%3Y

%5Y

Performance

242%1Y

155%3Y

147%5Y

Volatility

1126 M

Market cap (USD)

906,342

Daily traded volume (Shares)

55.19 / 52.6

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

2 votes

Performance:

4.50

Innovation:

4.00

Society:

4.00

Nature:

4.00

Alex Roberts

United Kingdom, 17 Dec 2025

Should've listened to this guy -->

Alex Roberts

United Kingdom, 20 Nov 2025

up 40% since I added a month ago, bounce back after potential lawsuit. Potential takeover looming

EQUITIES OF THE SAME SECTOR

Morningstar Inc

Morningstar Inc Valor: 1284731

Annual Return

-50%0%+50%

Risk level

110

5.74%USD 182.31

Tradeweb Markets Inc

Tradeweb Markets Inc Valor: 46837409

Annual Return

-50%0%+50%

Risk level

110

1.00%USD 121.96

SEI Investments Company

SEI Investments Company Valor: 969501

Annual Return

-50%0%+50%

Risk level

110

1.83%USD 83.30

AGNC Investment Corp

AGNC Investment Corp Valor: 34063784

Annual Return

-50%0%+50%

Risk level

110

0.53%USD 11.35

Hertz Global Holdings Inc

Hertz Global Holdings Inc Valor: 112420011

Annual Return

-50%0%+50%

Risk level

110

1.81%USD 4.50

Pinnacle Financial Partners Inc

Pinnacle Financial Partners Inc Valor: 1113591

Annual Return

-50%0%+50%

Risk level

110

0.78%USD 96.11

Selective Insurance Group Inc

Selective Insurance Group Inc Valor: 969546

Annual Return

-50%0%+50%

Risk level

110

1.11%USD 83.79

Bank OZK

Bank OZK Valor: 42805769

Annual Return

-50%0%+50%

Risk level

110

0.57%USD 49.31

Van Lanschot Kempen N.V.

Van Lanschot Kempen N.V. Valor: 821784

Annual Return

-50%0%+50%

Risk level

110

7.75%EUR 54.20

Qifu Technology, Inc

Qifu Technology, Inc Valor: 44558368

Annual Return

-50%0%+50%

Risk level

110

2.12%USD 14.90

Logos provided by Clearbit

MoonLake Immunotherapeutics

MLTX

ISIN KY61559X1045 / Valor 118139749

MoonLake Immunotherapeutics UMushroom community rating:

Alex Roberts

Alex Roberts

MoonLake Immunotherapeutics
UMushroom community rating: